Trichostatin A Attenuates Airway Inflammation in Mouse Asthma Model

  • Park, Jae-hoon (Department of Veterinary Pathology, College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University) ;
  • Oh, Se-woong (Department of Veterinary Pathology, College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University) ;
  • Kang, Min-soo (Department of Veterinary Pathology, College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University) ;
  • Kwon, Ho-jeong (Department of Bioscience and Biotechnology, Sejong University) ;
  • Oh, Goo-taeg (Korea Research Institute of Bioscience and Biotechnolog) ;
  • Kim, Dae-yong (Department of Veterinary Pathology, College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University)
  • Published : 2003.10.01

Abstract

Histone deacetylase (HDAC) inhibition has been demonstrated to change the expressions of a restricted set of cellular genes, T cells have an essential role in the pathogenesis of allergen-induced airway inflammation [1]. In recent studies, it has been demonstrated that treatment with HDAC inhibitors induces a T cell-suppressive effect [2]. The purpose of this study was to determine whether treatment with trichostatin A (TSA), a representative HDAC inhibitor, would reduce the allergen-induced airway inflammation in a mouse asthma model. (omitted)

Keywords